Management of phenytoin-induced gingival enlargement: a case report.
Gingival enlargements may adversely affect speech, mastication, tooth eruption, and esthetics. These enlargements can occur as a result of the administration of certain anticonvulsants, immunosuppressants, and calcium channel blockers. The present case report describes the treatment of a patient with a phenytoin-induced gingival enlargement. A case of gingival enlargement should be treated in a step-wise manner, including consultation with the patient's physician, substitution of the drug, nonsurgical therapy, surgical therapy (if needed), and supportive periodontal therapy after every 3 months. In this case, healing was uneventful, and no recurrences occurred 3 months postoperatively.
Rajkumar N
RN
Parwani
Simran R
SR
Parwani
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D005260:Female; D005881:Gingiva / Q000187:drug effects / Q000473:pathology / Q000601:surgery; D005882:Gingival Diseases / Q000139:chemically induced* / Q000473:pathology / Q000601:surgery; D005890:Gingivectomy; D005893:Gingivoplasty; D006801:Humans; D010672:Phenytoin / Q000009:adverse effects*; D011862:Radiography, Panoramic
D000927:Anticonvulsants; D010672:Phenytoin
drug-induced; gingival enlargement; phenytoin